Skip to main content
Debra Simmons, MD, Endocrinology, Salt Lake City, UT, John L. McClellan Memorial Veterans' Hospital

DebraLynnSimmonsMD

Endocrinology Salt Lake City, UT

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology

Assistant Professor of Medicine, University Ark

Dr. Simmons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Simmons' full profile

Already have an account?

  • Office

    615 Arapeen Drive, Salt Lake City, UT
    100
    Salt Lake City, UT 84108
    Phone+1 801-581-7761
    Fax+1 801-587-3920
  • Is this information wrong?

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1988
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 1982 - 1985
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1982

Certifications & Licensure

  • UT State Medical License
    UT State Medical License 2012 - 2024
  • AR State Medical License
    AR State Medical License 1997 - 2023
  • TX State Medical License
    TX State Medical License 1983 - 2022
  • CA State Medical License
    CA State Medical License 1985 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Fellow (FACE) American Association of Clinical Endocrinology

Publications & Presentations

PubMed

Press Mentions

  • Experimental Drug Could Be New Option for Type 2 Diabetes
    Experimental Drug Could Be New Option for Type 2 DiabetesJanuary 18th, 2019

Professional Memberships

Hospital Affiliations